A 2520-gm infant girl was born at 35 weeks' gestation to a 29-year-old primigravida who had reported her pregnancy as entirely normal until spontaneous rupture of membranes 18 hours before delivery. The mother received intrapartum penicillin because of an unknown group B streptococcus status. Labor was augmented with oxytocin, and an epidural catheter was placed with morphine administered for analgesia. The infant was delivered vaginally. A tight nuchal cord was clamped and cut after delivery of the head. The baby was initially depressed and received bag and mask ventilation with 100% oxygen for 15 seconds. Apgar scores were 5 and 8 at 1 and 5 minutes, respectively. On physical examination the baby was hypotonic; she was noted to have horizontal nystagmus with an intermittent rotary component in both eyes. She was admitted to the neonatal intensive care unit for further observation.
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Within an hour, she was noted to have marked improvement in her neuromuscular tone, but persistence of the nystagmus. The remainder of her physical examination was unremarkable. Evaluation of venous blood gases revealed a pH of 7.31, PCO 2 of 37 torr, PO 2 of 36 torr, and HCO 3 Ϫ of 19 meq/liter while breathing room air. She was treated with ampicillin, gentamicin, and intravenous fluids. Enteral feeds were initiated subsequently and tolerated at 24 hours of age. Antibiotics were discontinued at 36 hours following a negative blood culture. She required a small amount of nasal cannula oxygen to maintain adequate arterial oxygen saturation. She fed well, maintained adequate urine output, and had no systemic signs of hypoxic-ischemic dysfunction. Her neurologic evaluation included normal brainstem audiometric-evoked responses, a structurally normal cranial sonogram, and normal fundoscopy. A multichannel sleep study was performed on day 5 of life; this study showed disorganized breathing with arterial oxygen desaturation, especially with feeds, which improved with the administration of oxygen. The nystagmus was observed intermittently over the first 24 hours of life but became less frequent; by 72 hours, it had completely resolved. On further questioning, the mother revealed that she had been treated with sertraline hydrochloride (Zoloft), 50 mg/day, for 2 weeks before delivery for anxiety and depression.
The infant was discharged at 1 week of age on nasal cannula oxygen at 0.5 LPM but with an otherwise normal physical examination. At 1 month of age, she was growing well with no evidence of nystagmus or other neurologic deficits, and she had been weaned from the supplemental oxygen.
DISCUSSION
Sertraline hydrochloride belongs to the class of selective serotonin reuptake inhibitors (SSRIs), which are widely prescribed for the treatment of depression. Other agents currently available in the United States include fluoxetine (Prozac), paroxetine (Paxil), and fluvoxamine (Luvox). The mechanism of action is presumed to be linked to the inhibition of the neuronal uptake of serotonin (5-hydroxytryptamine) into the presynaptic terminal. The drug is absorbed in the gastrointestinal tract and metabolized in the liver to N-desmethylsertraline. Sertraline hydrochloride has an elimination half-life (t 1/2 ) of 26 hours; its metabolite N-desmethylsertraline has a t 1/2 of 62 to 104 hours and is substantially less active than sertraline. Fluoxetine has the longest t 1/2 (1 to 4 days), and its primary metabolite, norfluoxetine, is as potent an inhibitor of serotonin as its parent compound. 1 Both paroxetine and fluvoxamine have a t 1/2 similar to sertraline (24 hours), and their primary metabolites appear to be inactive. 1 Common side effects of SSRIs include gastrointestinal problems (nausea, vomiting, and diarrhea) and central nervous system dysfunction (agitation, disinhibition, headache, insomnia, and tremors). Infrequent adverse effects reported by individuals that have been administered multiple doses of sertraline (as well as fluoxetine and paroxetine) have included nystagmus and, rarely, hypotonia.
2 Two cases of neonatal neurologic side effects of maternally administered fluoxetine hydrochloride (Prozac) have been published. In the first, an infant exhibited central nervous system problems, including temperature instability, jitteriness, tremors, irritability, hypertonia, and laterally roving eyes. Cord blood sampling revealed a fluoxetine concentration below the therapeutic adult level (40 to 350 ng/ml); the norfluoxetine level was within the therapeutic range (30 to 325 ng/ml). 3 The second case described extreme jitteriness, hypertonia, and petechiae in an infant exposed to fluoxetine throughout pregnancy. Serum concentrations for both fluoxetine and its metabolite were within the adult therapeutic range at birth. 4 In both cases, signs resolved within 96
hours, consistent with the t 1/2 of fluoxetine. To date, there are no such descriptions for sertraline. Although we were unable to document the plasma concentration of sertraline (cord blood was not drawn, and the positive history was not obtained until well past the elimination t 1/2 ), the clinical course of the infant suggests that the etiology of her nystagmus might well be explained by prenatal exposure to sertraline. The t 1/2 of 26 hours temporally correlates with the resolution of her nystagmus. The mother also discontinued the medication after delivery, and she did not breastfeed the infant for 72 hours. Many women develop or have a recurrence of psychiatric illness during pregnancy; the postpartum period may be vulnerable for the development of mood disorders while breastfeeding. Recent studies show that up to 35% of pregnant women may be using psychoactive drugs. 5 Despite increasing prevalence of the use of SSRIs, there is little in the literature describing the safety of these drugs in pregnancy and lactation. Several studies have examined in utero exposure to SSRIs in both animals and humans; all have involved fluoxetine. Fluoxetine and its metabolite have been shown to easily cross the placenta in rats. 6 Animal studies using up to 11 times the maximum daily dose of fluoxetine for humans have demonstrated no teratogenic effect on exposed fetuses. 6 The rates of major fetal malformations among fluoxetine-treated mothers during the first and third trimester do not vary from those expected in the general population (1% to 3%); the rate of miscarriage was higher than nondepressed control patients treated with nonteratogens but was considered similar to the general population rate of 15%. 6 It is well established that all psychotropic agents are secreted into human milk in varying concentrations. Various studies have found that 3.3% to 10.8% of the maternal dose of fluoxetine is ingested by breastfed infants; there have been no reports of serious side effects in infants exposed to SSRIs from human milk, and their use is not presently a contraindication to breastfeeding. 7 Nystagmus can be described as pendular (to-and-fro eye movements of equal amplitude in both directions) or jerky (slow component in one direction and a fast component in the opposite direction). Physiological nystagmus can be elicited by the optokinetic phenomenon of a target moving past the eyes, resulting in a jerky nystagmus. Vestibular nystagmus can occur with rotation of the body or irrigation of the ear canal and is caused by movement of the fluid within the semicircular canals. It results in jerky nystagmus that is horizontal and torsional. 8 Positional nystagmus may be seen in extreme gaze and is usually in the horizontal direction. Ocular, neurologic, or vestibular defects can result in pathologic nystagmus (Table 1) . Optic nerve hypoplasia or atrophy, macular scars, retinal disorders, cataracts, aniridia, and albinism are ocular defects that can result in congenital pendular nystagmus. Underlying neurologic conditions such as posterior fossa lesions or defects in the gaze mechanism caused by brainstem or cerebellar abnormalities can also result in nystagmus. Central or peripheral defects in the vestibular system usually cause jerky nystagmus. 9 Congenital jerky nystagmus is familial and can be diagnosed early in life. Its inheritance is either autosomal dominant, recessive, or X-linked. 10 With the increasing use of SSRIs and their potential use during pregnancy, it is important for care providers to be aware of potential side effects in the newborn, particularly nystagmus. This unusual clinical finding calls for a detailed prenatal history and a thorough physical examination. Differentiating transient drug-induced nystagmus from a more serious disorder may obviate the need for invasive or ionizing diagnostic studies.
